LAPOINTE ANTHONY GREGG — SEC Form 4 filings
SEC reporting owner CIK 1331860. 9 Form 4 filings on record with FilingPulse; latest filed 2026-09-18.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-05-29 to 2026-09-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 15.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Astria Therapeutics, Inc. (ATXS) | Director | 3 | — | — | 7 |
| RIGEL PHARMACEUTICALS INC (RIGL) | Director | 3 | — | — | 5 |
| SOLIGENIX, INC. (SNGX) | Director | 3 | — | — | 3 |
Form 4 filings — LAPOINTE ANTHONY GREGG
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-18 | 4 | SOLIGENIX, INC. (SNGX) | Grant/award (A): 78,947 (derivative) @ $0 | EDGAR |
| 2026-05-19 | 4 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/award (A): 5,750 @ $0 | EDGAR |
| 2026-01-23 | 4 | Astria Therapeutics, Inc. (ATXS) | Disposition to issuer (D): 16,666 (derivative) · Disposition to issuer (D): 8,333 (derivative) · Disposition to issuer (D): 14,100 (derivative) · Disposition to issuer (D): 14,100 (derivative) · Disposition to issuer (D): 26,550 (derivative) | EDGAR |
| 2025-06-20 | 4 | SOLIGENIX, INC. (SNGX) | Grant/award (A): 17,647 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | Astria Therapeutics, Inc. (ATXS) | Grant/award (A): 26,550 (derivative) @ $0 | EDGAR |
| 2025-05-28 | 4 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/award (A): 2,500 @ $0 · Grant/award (A): 3,000 (derivative) @ $0 | EDGAR |
| 2024-12-13 | 4 | SOLIGENIX, INC. (SNGX) | Grant/award (A): 8,646 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | Astria Therapeutics, Inc. (ATXS) | Grant/award (A): 14,100 (derivative) @ $0 | EDGAR |
| 2024-05-29 | 4 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/award (A): 25,000 @ $0 · Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1331860 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →